Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Amanda S. Latham"'
Publikováno v:
Frontiers in Aging, Vol 4 (2023)
Neuroinflammation is a universal characteristic of brain aging and neurological disorders, irrespective of the disease state. Glial inflammation mediates this signaling, through astrocyte and microglial polarization from neuroprotective to neurotoxic
Externí odkaz:
https://doaj.org/article/008469a5056f4a7c8be1e3b96ec7765a
Autor:
Amanda S. Latham, Charlize E. Geer, David F. Ackart, Isla K. Anderson, Kaley M. Vittoria, Brendan K. Podell, Randall J. Basaraba, Julie A. Moreno
Publikováno v:
Frontiers in Neuroscience, Vol 17 (2023)
Tuberculosis, caused by Mycobacterium tuberculosis infection, is an ongoing epidemic with an estimated ten million active cases of the disease worldwide. Pulmonary tuberculosis is associated with cognitive and memory deficits, and patients with this
Externí odkaz:
https://doaj.org/article/0dc3cb2aa699433f855868582cd2883e
Autor:
Arielle J. D. Hay, Amanda S. Latham, Genova Mumford, Amelia D. Hines, Sydney Risen, Elizabeth Gordon, Connor Siebenaler, Vincenzo S. Gilberto, Mark D. Zabel, Julie A. Moreno
Publikováno v:
Frontiers in Neuroscience, Vol 17 (2023)
Mesenchymal stromal cells (MSCs) are an intriguing avenue for the treatment of neurological disorders due to their ability to migrate to sites of neuroinflammation and respond to paracrine signaling in those sites by secreting cytokines, growth facto
Externí odkaz:
https://doaj.org/article/dc6fcc63d1044053ab6439989e38bd95
Autor:
Amelia D. Hines, Stephanie McGrath, Amanda S. Latham, Breonna Kusick, Lisa Mulligan, McKenzie L. Richards, Julie A. Moreno
Publikováno v:
Frontiers in Aging Neuroscience, Vol 15 (2023)
Canine cognitive dysfunction (CCD) syndrome is a well-recognized naturally occurring disease in aged dogs, with a remarkably similar disease course, both in its clinical presentation and neuropathological changes, as humans with Alzheimer’s disease
Externí odkaz:
https://doaj.org/article/665191882b2a453aa6a11713bea4adea
Autor:
Savannah M. Rocha, Anna C. Fagre, Amanda S. Latham, Jason E. Cummings, Tawfik A. Aboellail, Philip Reigan, Devin A. Aldaz, Casey P. McDermott, Katriana A. Popichak, Rebekah C. Kading, Tony Schountz, Neil D. Theise, Richard A. Slayden, Ronald B. Tjalkens
Publikováno v:
Frontiers in Immunology, Vol 13 (2022)
Despite significant research efforts, treatment options for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) remain limited. This is due in part to a lack of therapeutics that increase host defense to the virus. Replication of SARS-CoV-2
Externí odkaz:
https://doaj.org/article/042ff2a87d9a449d818ce9b18173369f
Autor:
Savannah M. Rocha, Anna C. Fagre, Amanda S. Latham, Katriana A. Popichak, Casey P. McDermott, Clinton C. Dawson, Jason E. Cummings, Juliette Lewis, Philip Reigan, Tawfik A. Aboellail, Rebekah C. Kading, Tony Schountz, Neil D. Theise, Richard A. Slayden, Ronald B. Tjalkens
Since its initial discovery in late 2019, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the cause of COVID19, has spread worldwide and despite significant research efforts, treatment options remain limited. Replication of SARS-CoV-2 i
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::0ad93a5416c6c7abf235bc615ce2d3f9
https://doi.org/10.1101/2021.02.20.432110
https://doi.org/10.1101/2021.02.20.432110